eXoZymes, Inc. (EXOZ) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Monrovia, NV, 미국. 현재 CEO는 Michael Heltzen.
EXOZ 을(를) 보유 IPO 날짜 2024-11-13, 31 명의 정규직 직원, 에 상장 NASDAQ Global Market, 시가총액 $91.91M.
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.
